In this study, we observed a significant correlation (p≤ 0.05) between the DTH-PPD responses in BCG treated melanoma patients and the four gene SNPs from our panel: IL1β, NRAMP1/SLC11A1, and CXCL12. The gene discussed is SLC11A1; the disease is melanoma.